Literature DB >> 17263669

A gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury.

Wei-Min Gao1, Mandeep S Chadha, Rachel P Berger, Gilbert S Omenn, David L Allen, Michael Pisano, P David Adelson, Robert S B Clark, Larry W Jenkins, Patrick M Kochanek.   

Abstract

Traumatic brain injury (TBI) is the most common cause of traumatic death in infancy, and inflicted TBI (iTBI) is the predominant cause. Like other central nervous system pathologies, TBI changes the composition of cerebrospinal fluid (CSF), which may represent a unique clinical window on brain pathophysiology. Proteomic analysis, including two-dimensional (2-D) difference in gel electrophoresis (DIGE) combined with mass spectrometry (MS), was used to compare the CSF protein profile of two pooled samples from pediatric iTBI (n = 13) and non-inflicted TBI (nTBI; n = 13) patients with severe injury. CSF proteins from iTBI and nTBI were fluorescently labeled in triplicate using different fluorescent Cy dyes and separated by 2-D gel electrophoresis. Approximately 250 protein spots were found in CSF, with 90% between-gel reproducibility of the 2-D gel. Following in-gel digestion, the tryptic peptides were analyzed by MS for protein identification. The acute phase reactant, haptoglobin (HP) isoforms, showed an approximate fourfold increase in nTBI versus iTBI. In contrast, the levels of prostaglandin D(2) synthase (PGDS) and cystatin C (CC) were 12-fold and sevenfold higher in iTBI versus nTBI, respectively. The changes of HP, PGDS, and CC were confirmed by Western blot. These initial results with conventional gel-based proteomics show new protein changes that may ultimately help to understand pathophysiological differences between iTBI and nTBI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17263669      PMCID: PMC2721471          DOI: 10.1089/neu.2006.0061

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  46 in total

1.  Serum cystatin C concentration as a marker of renal dysfunction in the elderly.

Authors:  D Fliser; E Ritz
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

Review 2.  Application of acute phase protein measurements in veterinary clinical chemistry.

Authors:  Henrik Hagbard Petersen; Jens Peter Nielsen; Peter Mikael Helweg Heegaard
Journal:  Vet Res       Date:  2004 Mar-Apr       Impact factor: 3.683

Review 3.  Childhood injuries in the United States. Division of Injury Control, Center for Environmental Health and Injury Control, Centers for Disease Control.

Authors: 
Journal:  Am J Dis Child       Date:  1990-06

Review 4.  Shaken baby syndrome.

Authors:  R F Spaide; R M Swengel; D W Scharre; C E Mein
Journal:  Am Fam Physician       Date:  1990-04       Impact factor: 3.292

5.  Microglial secreted cathepsin B induces neuronal apoptosis.

Authors:  P J Kingham; J M Pocock
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

6.  The systemic and local acute phase response following acute brain injury.

Authors:  David C Wilcockson; Sandra J Campbell; Daniel C Anthony; V Hugh Perry
Journal:  J Cereb Blood Flow Metab       Date:  2002-03       Impact factor: 6.200

7.  The shaken baby syndrome. A clinical, pathological, and biomechanical study.

Authors:  A C Duhaime; T A Gennarelli; L E Thibault; D A Bruce; S S Margulies; R Wiser
Journal:  J Neurosurg       Date:  1987-03       Impact factor: 5.115

8.  Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells.

Authors:  P Pierre; I Mellman
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

9.  Proteome study of human cerebrospinal fluid following traumatic brain injury indicates fibrin(ogen) degradation products as trauma-associated markers.

Authors:  Antonio Conti; Yovan Sanchez-Ruiz; Angela Bachi; Luigi Beretta; Elisabetta Grandi; Massimiliano Beltramo; Massimo Alessio
Journal:  J Neurotrauma       Date:  2004-07       Impact factor: 5.269

10.  The Th1 versus Th2 cytokine profile in cerebrospinal fluid after severe traumatic brain injury in infants and children.

Authors:  Jonathan E. Amick; Kristin A. Yandora; Michael J. Bell; Stephen R. Wisniewski; P. David Adelson; Joseph A. Carcillo; Keri L. Janesko; Steven T. DeKosky; Timothy M. Carlos; Robert S.B. Clark; Patrick M. Kochanek
Journal:  Pediatr Crit Care Med       Date:  2001-07       Impact factor: 3.624

View more
  19 in total

1.  Acute Phase Proteins in Cerebrospinal Fluid from Dogs with Naturally-Occurring Spinal Cord Injury.

Authors:  Kimberly M Anderson; C Jane Welsh; Colin Young; Gwendolyn J Levine; Sharon C Kerwin; C Elizabeth Boudreau; Ismael Reyes; Armando Mondragon; John F Griffin; Noah D Cohen; Jonathan M Levine
Journal:  J Neurotrauma       Date:  2015-07-17       Impact factor: 5.269

2.  α-Synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: the effect of therapeutic hypothermia.

Authors:  Erik Su; Michael J Bell; Stephen R Wisniewski; P David Adelson; Keri L Janesko-Feldman; Rosanne Salonia; Robert S B Clark; Patrick M Kochanek; Valerian E Kagan; Hülya Bayır
Journal:  Dev Neurosci       Date:  2010-12-02       Impact factor: 2.984

3.  Metabolic crisis after traumatic brain injury is associated with a novel microdialysis proteome.

Authors:  R Lakshmanan; J A Loo; T Drake; J Leblanc; A J Ytterberg; D L McArthur; M Etchepare; P M Vespa
Journal:  Neurocrit Care       Date:  2010-06       Impact factor: 3.210

Review 4.  Quo vadis 2010? - carpe diem: challenges and opportunities in pediatric traumatic brain injury.

Authors:  Patrick M Kochanek; Michael J Bell; Hülya Bayır
Journal:  Dev Neurosci       Date:  2011-01-21       Impact factor: 2.984

5.  Variations in the cerebrospinal fluid proteome following traumatic brain injury and subarachnoid hemorrhage.

Authors:  David E Connor; Ganta V Chaitanya; Prashant Chittiboina; Paul McCarthy; L Keith Scott; Lisa Schrott; Alireza Minagar; Anil Nanda; J Steven Alexander
Journal:  Pathophysiology       Date:  2017-05-13

6.  Neuroproteomics: a biochemical means to discriminate the extent and modality of brain injury.

Authors:  Andrew K Ottens; Liliana Bustamante; Erin C Golden; Changping Yao; Ronald L Hayes; Kevin K W Wang; Frank C Tortella; Jitendra R Dave
Journal:  J Neurotrauma       Date:  2010-10-09       Impact factor: 5.269

7.  Screening of biochemical and molecular mechanisms of secondary injury and repair in the brain after experimental blast-induced traumatic brain injury in rats.

Authors:  Patrick M Kochanek; C Edward Dixon; David K Shellington; Samuel S Shin; Hülya Bayır; Edwin K Jackson; Valerian E Kagan; Hong Q Yan; Peter V Swauger; Steven A Parks; David V Ritzel; Richard Bauman; Robert S B Clark; Robert H Garman; Faris Bandak; Geoffrey Ling; Larry W Jenkins
Journal:  J Neurotrauma       Date:  2013-06-05       Impact factor: 5.269

Review 8.  Application of "omics" to prion biomarker discovery.

Authors:  Rhiannon L C H Huzarewich; Christine G Siemens; Stephanie A Booth
Journal:  J Biomed Biotechnol       Date:  2010-03-04

9.  Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders.

Authors:  Abhilash Venugopal; Raghothama Chaerkady; Akhilesh Pandey
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

Review 10.  Traumatic brain injury in children: recent advances in management.

Authors:  Michael J Bell; Patrick M Kochanek
Journal:  Indian J Pediatr       Date:  2009-01-07       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.